HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Laryngeal Neoplasms D007822 7 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Pleural Effusion, Malignant D016066 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Sounds D012135 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Hirschsprung Disease D006627 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Mercury Poisoning, Nervous System D020262 2 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Carcinosarcoma D002296 7 associated lipids
Eosinophilic Esophagitis D057765 3 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Mucinoses D017520 2 associated lipids
Choroid Neoplasms D002830 2 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Thyroid Nodule D016606 4 associated lipids
Glucagonoma D005935 2 associated lipids
Vascular Neoplasms D019043 2 associated lipids
Fetomaternal Transfusion D005331 1 associated lipids
Schistosomiasis haematobia D012553 1 associated lipids
Paraganglioma, Extra-Adrenal D010236 1 associated lipids
Mesonephroma D008649 1 associated lipids
Adenoma, Oxyphilic D018249 1 associated lipids
Adenoma, Pleomorphic D008949 1 associated lipids
Odontogenic Cyst, Calcifying D018333 1 associated lipids
Lip Neoplasms D008048 3 associated lipids
Prostatic Intraepithelial Neoplasia D019048 1 associated lipids
Granular Cell Tumor D016586 1 associated lipids
Tooth Attrition D019217 1 associated lipids
Acanthamoeba Keratitis D015823 1 associated lipids
Cystadenocarcinoma, Papillary D018283 1 associated lipids
Nevus, Epithelioid and Spindle Cell D018332 1 associated lipids
Neoplasms, Connective and Soft Tissue D018204 1 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Rhabdomyoma D012207 1 associated lipids
Angiomyolipoma D018207 1 associated lipids
Sertoli Cell Tumor D012707 1 associated lipids
Neoplasms, Fibroepithelial D018225 1 associated lipids
Dientamoebiasis D004030 1 associated lipids
HIV Enteropathy D019053 1 associated lipids
Linear IgA Bullous Dermatosis D062027 1 associated lipids
Equine Infectious Anemia D004859 1 associated lipids
Sarcoma, Endometrial Stromal D018203 1 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Robinson SP et al. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. 2003 Br. J. Cancer pmid:12771928
Wani KM et al. Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma. 2003 Br. J. Cancer pmid:12771926
Kim TJ et al. Increased expression of pAKT is associated with radiation resistance in cervical cancer. 2006 Br. J. Cancer pmid:16721365
Tsutsui S et al. A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer. 2006 Br. J. Cancer pmid:16721362
Jamerson MH et al. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. 2004 Br. J. Cancer pmid:15354213
Ribatti D et al. Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma. 2006 Br. J. Cancer pmid:16721359
Nieto Y et al. Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. 2007 Br. J. Cancer pmid:17609662
Zaman MS et al. The functional significance of microRNA-145 in prostate cancer. 2010 Br. J. Cancer pmid:20588276
Kupryjańczyk J et al. TP53 status determines clinical significance of ERBB2 expression in ovarian cancer. 2004 Br. J. Cancer pmid:15545967
Alì G et al. Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact. 2009 Br. J. Cancer pmid:19935800
Overman MJ et al. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. 2010 Br. J. Cancer pmid:19935793
Zlobec I et al. Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. 2010 Br. J. Cancer pmid:19935791
Aoki S et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. 2003 Br. J. Cancer pmid:12618882
Colpaert CG et al. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. 2003 Br. J. Cancer pmid:12618881
Koukourakis MI et al. Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference? 2003 Br. J. Cancer pmid:12618880
Caldwell GM et al. Reorganisation of Wnt-response pathways in colorectal tumorigenesis. 2008 Br. J. Cancer pmid:18414471
Bridgewater J et al. Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. 2008 Br. J. Cancer pmid:18414470
Darby S et al. Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease. 2009 Br. J. Cancer pmid:19888221
Kato K et al. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. 2008 Br. J. Cancer pmid:18665171
Stumpf M et al. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. 2009 Br. J. Cancer pmid:19861998
Le Page C et al. Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. 2006 Br. J. Cancer pmid:16721361
Salgado R et al. Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer. 2002 Br. J. Cancer pmid:12454774
Rajaganeshan R et al. The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. 2007 Br. J. Cancer pmid:17353920
Tuynman JB et al. Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma. 2008 Br. J. Cancer pmid:18349821
McCall P et al. Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients. 2008 Br. J. Cancer pmid:18349820
Park SW et al. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. 2004 Br. J. Cancer pmid:15266310
Elsir T et al. PROX1 is a predictor of survival for gliomas WHO grade II. 2011 Br. J. Cancer pmid:21559010
Fujimori K et al. Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma. 2005 Br. J. Cancer pmid:15655559
van Hattum AH et al. Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity. 2002 Br. J. Cancer pmid:12237778
Watters AD et al. Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer. 2002 Br. J. Cancer pmid:12237776
Mukherjee P et al. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. 2002 Br. J. Cancer pmid:12085212
Hoskin PJ et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. 2003 Br. J. Cancer pmid:14520462
Vizoso FJ et al. Study of matrix metalloproteinases and their inhibitors in breast cancer. 2007 Br. J. Cancer pmid:17342087
West NP et al. The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. 2010 Br. J. Cancer pmid:20407439
Woodhams JH et al. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver. 2004 Br. J. Cancer pmid:15266317
Akahira JI et al. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. 2004 Br. J. Cancer pmid:15164121
Gisselsson D et al. Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. 2004 Br. J. Cancer pmid:15162157
Liggins AP et al. A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein. 2004 Br. J. Cancer pmid:15162151
Lee YC et al. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. 2004 Br. J. Cancer pmid:15150628
Wang YF et al. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. 2004 Br. J. Cancer pmid:15150613
Hall GH et al. Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours. 2002 Br. J. Cancer pmid:12085262
Staal FJ et al. A novel germline mutation of PTEN associated with brain tumours of multiple lineages. 2002 Br. J. Cancer pmid:12085208
Ito Y et al. Expression of cdc25A and cdc25B proteins in thyroid neoplasms. 2002 Br. J. Cancer pmid:12085185
Hu L et al. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. 2010 Br. J. Cancer pmid:20354527
Berta GN et al. Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas. 2005 Br. J. Cancer pmid:16265350
Islami F et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. 2004 Br. J. Cancer pmid:15054463
Molleví DG et al. PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. 2008 Br. J. Cancer pmid:19002188
Buffart TE et al. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. 2008 Br. J. Cancer pmid:19002170
Mah-Becherel MC et al. Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model. 2002 Br. J. Cancer pmid:11875746
Hague S et al. Tamoxifen induction of angiogenic factor expression in endometrium. 2002 Br. J. Cancer pmid:11875740
Weigelt B et al. No common denominator for breast cancer lymph node metastasis. 2005 Br. J. Cancer pmid:16189523
Van Valckenborgh E et al. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. 2002 Br. J. Cancer pmid:11875745
Schrader C et al. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. 2005 Br. J. Cancer pmid:16189522
Shields JD et al. Lymphatic density and metastatic spread in human malignant melanoma. 2004 Br. J. Cancer pmid:14760386
Adib TR et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays. 2004 Br. J. Cancer pmid:14760385
Kawaguchi K et al. Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype. 2004 Br. J. Cancer pmid:14760383
Choudhury A et al. MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. 2004 Br. J. Cancer pmid:14760381
Reddy A et al. Analysis of CHK2 in vulval neoplasia. 2002 Br. J. Cancer pmid:11875739
Duncan R et al. Characterisation and protein expression profiling of annexins in colorectal cancer. 2008 Br. J. Cancer pmid:18071363
Murri AM et al. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. 2008 Br. J. Cancer pmid:18797461
Tabori U et al. Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. 2008 Br. J. Cancer pmid:18797459
Wang EL et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. 2010 Br. J. Cancer pmid:20145615
Loussouarn D et al. Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. 2009 Br. J. Cancer pmid:19513072
Charalambous MP et al. Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. 2009 Br. J. Cancer pmid:19513071
Atkin GK et al. The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. 2006 Br. J. Cancer pmid:17016487
Dietze A et al. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. 2005 Br. J. Cancer pmid:15886704
Hori K and Saito S Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. 2003 Br. J. Cancer pmid:14520469
Latif Z et al. HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder. 2003 Br. J. Cancer pmid:14520464
Talvensaari-Mattila A et al. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. 2003 Br. J. Cancer pmid:14520459
Geoerger B et al. Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. 2003 Br. J. Cancer pmid:12888833
Bhoopathi P et al. The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. 2010 Br. J. Cancer pmid:20087345
Mahalingam D et al. Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. 2010 Br. J. Cancer pmid:20087343
Shuyama K et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. 2007 Br. J. Cancer pmid:17453003
Shannon AM et al. Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. 2005 Br. J. Cancer pmid:15999100
Oosterhoff D et al. Secreted and tumour targeted human carboxylesterase for activation of irinotecan. 2002 Br. J. Cancer pmid:12237777
Youssef MM et al. EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer. 2006 Br. J. Cancer pmid:16929248
Rennel E et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. 2008 Br. J. Cancer pmid:18349828
Tsuji S et al. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. 2010 Br. J. Cancer pmid:20628387
Santin AD et al. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. 2005 Br. J. Cancer pmid:15785748
Mimori K et al. Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. 2006 Br. J. Cancer pmid:16721363
Maruyama T et al. Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma. 2010 Br. J. Cancer pmid:20628381
Arrieta O et al. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. 2005 Br. J. Cancer pmid:15785746
Polterauer S et al. The impact of lymph node density on survival of cervical cancer patients. 2010 Br. J. Cancer pmid:20628380
Saeb-Parsy K et al. MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3. 2008 Br. J. Cancer pmid:18665176
Mimura K et al. Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma. 2005 Br. J. Cancer pmid:15785739
Tanaka N et al. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. 2003 Br. J. Cancer pmid:12888830
Sonoda K et al. Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. 2003 Br. J. Cancer pmid:12888828
Raccurt M et al. Suppressor of cytokine signalling gene expression is elevated in breast carcinoma. 2003 Br. J. Cancer pmid:12888825
Marikovsky M Thiram inhibits angiogenesis and slows the development of experimental tumours in mice. 2002 Br. J. Cancer pmid:11875743
Chatrath P et al. Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia. 2006 Br. J. Cancer pmid:16832409
Van Laere SJ et al. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. 2007 Br. J. Cancer pmid:17700572
Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. 2002 Br. J. Cancer pmid:12085263
McCarty MF et al. ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. 2004 Br. J. Cancer pmid:14760388
Gaya A et al. Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. 2008 Br. J. Cancer pmid:18612312
Arrieta O et al. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. 2008 Br. J. Cancer pmid:18594540
Hart CA et al. Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. 2005 Br. J. Cancer pmid:15668715
Nalwoga H et al. Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer. 2010 Br. J. Cancer pmid:20010944
Nakajima M et al. Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. 2003 Br. J. Cancer pmid:12771989
Cao P et al. Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts. 2009 Br. J. Cancer pmid:19319133
Charalambous MP et al. Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. 2003 Br. J. Cancer pmid:12771929